Novozymes went slightly up except for one division
The biofuel division was the only part of Novozymes to suffer a setback in 2016, according to the annual report on a "challenging year", in which the enzyme producer kicks off a round of firings and a large-scale share buy-back program.
Overall, Novozymes made progress in 2016. The enzyme producer's revenue increased slightly by 1 percent to DKK 14,142 million (EUR 1,902 million) while the result landed a good 7 percent above 2015 at DKK 3,881 before taxes, according to the annual report presented Wednesday morning.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novozymes welcomes new US biofuel requirements
For subscribers
.jpg&w=384&q=75){kind=logo}
